The Discounted Cash Flow (DCF) valuation of Neuropace Inc (NPCE) is (12.77) USD. With the latest stock price at 10.13 USD, the upside of Neuropace Inc based on DCF is -226.1%.
Based on the latest price of 10.13 USD and our DCF valuation, Neuropace Inc (NPCE) is a sell. selling NPCE stocks now will result in a potential gain of 226.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.1% - 9.3% | 8.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (23.62) - (9.17) | (12.77) |
| Upside | -333.2% - -190.5% | -226.1% |